The north St. Louis County-based company reported a net income of $543 million, or 67 cents per share, compared to $149.6 million, or 18 cents per share, a year ago.

More than 200 people attended a town hall Tuesday in Boswell to support a local pharmacy chain that is continuing a year-long fight against a multi-billion-dollar pharmaceutical ...

Fundraisers • Express Scripts will sponsor a golf scramble outing to benefit the Veterans Leadership Program at 2 p.m. July ...

WASHINGTON — Sen. Elizabeth Warren, D-Mass., urged the Defense Department to audit Express Scripts to determine if the pharmacy benefit manager is overcharging for prescriptions and steering military ...

For respondents facing novel Federal Trade Commission theories, the lesson is that early engagement—not reflexive litigation—can yield outcomes that address regulatory concerns while preserving ...

Nation’s largest Pharmacy Benefits Manager accused of gaming its drug formulary and withholding billions in rebates from PBM customers. NEW YORK--(BUSINESS WIRE)--Today, Bernstein Litowitz Berger & ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

Cost Plus Drugs founder Mark Cuban is not convinced the Federal Trade Commission’s settlement with Cigna’s Express Scripts is going to amount to very much. “My initial response to the FTC [and ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

The Federal Trade Commission has reached a landmark settlement with Express Scripts, one of the nation’s largest pharmacy benefit managers, requiring sweeping changes aimed at lowering insulin costs ...

The Federal Trade Commission said it has reached a settlement with Express Scripts, resolving an earlier lawsuit that alleged the pharmacy benefit manager artificially inflated insulin drug prices.